Acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia. Methylthioninium chloride Proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).
Methylthioninium Chloride is primarily used in the treatment of medicinal and chemical induced and genetic methaemoglobinaemia that are not due to a structural abnormality of haemoglobin. Methylthioninium Chloride is indicated in adults, and children and adolescents (aged 0 to 17 years old).
Theranica announced that the FDA granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra, utilizing Remote Electrical Neuromodulation...
Treatment of: • Major Depressive Episode • Obsessive Compulsive Disorder • Panic Disorder with and without agoraphobia • Social Anxiety Disorders / Social phobia • Generalised Anxiety Disorder • Post – traumatic Stress Disorder
Veloxis Pharmaceuticals announced that the FDA approved a new indication for Envarsus XR (tacrolimus extended-release tablets) to prevent organ rejection...
Treatment of - Major Depressive Episode - Obsessive Compulsive Disorder - Panic Disorder with and without agoraphobia - Social Anxiety Disorders/Social phobia - Generalised Anxiety Disorder - Post-traumatic Stress Disorder
Treatment of - Major depressive episode. - Obsessive Compulsive Disorder (OCD). - Panic disorder with and without agoraphobia. - Social anxiety disorders/social phobia. - Generalised anxiety disorder. - Post-traumatic stress disorder
Treatment of - Major Depressive Episodes - Obsessive Compulsive Disorder - Panic Disorder with and without agoraphobia - Social Anxiety Disorder/Social phobia - Generalised Anxiety Disorder - Post-traumatic Stress Disorder